European Union - English - EMA (European Medicines Agency)

pharmaand gmbh - darifenacin hydrobromide - urinary incontinence, urge; urinary bladder, overactive - urologicals, drugs for urinary frequency and incontinence - symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merus labs luxco s.a r.l. - darifenacin hydrobromide - modified-release tablet - 7.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merus labs luxco s.a r.l. - darifenacin hydrobromide - modified-release tablet - 15mg

Canada - English - Health Canada

searchlight pharma inc - darifenacin (darifenacin hydrobromide) - tablet (extended-release) - 7.5mg - darifenacin (darifenacin hydrobromide) 7.5mg - antimuscarinics

Canada - English - Health Canada

searchlight pharma inc - darifenacin (darifenacin hydrobromide) - tablet (extended-release) - 15mg - darifenacin (darifenacin hydrobromide) 15mg - antimuscarinics

Canada - English - Health Canada

apotex inc - darifenacin (darifenacin hydrobromide) - tablet (extended-release) - 15mg - darifenacin (darifenacin hydrobromide) 15mg - antimuscarinics

Canada - English - Health Canada

apotex inc - darifenacin (darifenacin hydrobromide) - tablet (extended-release) - 7.5mg - darifenacin (darifenacin hydrobromide) 7.5mg - antimuscarinics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - darifenacin hydrobromide - modified-release tablet - 15mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - darifenacin hydrobromide - prolonged-release tablet - 15 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

aspen pharma trading limited (aptl), ireland - darifenacin hydrobromide - prolonged-release tablet - 15 mg